TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biobasiq Sverige AB
Closing information (x1000 SEK)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
30,689
|
26,402 | |
| Financial expenses |
53
|
45 | |
| Earnings before taxes |
2,019
|
73 | |
| EBITDA |
1,975
|
66 | |
| Total assets |
9,628
|
7,901 | |
| Current assets |
9,628
|
7,901 | |
| Current liabilities |
2,673
|
2,549 | |
| Equity capital |
6,955
|
5,352 | |
| - share capital |
100
|
100 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
72.2%
|
67.7% | |
| Turnover per employee |
15,344
|
13,201 | |
| Profit as a percentage of turnover |
6.6%
|
0.3% | |
| Return on assets (ROA) |
21.5%
|
1.5% | |
| Current ratio |
360.2%
|
310.0% | |
| Return on equity (ROE) |
29.0%
|
1.4% | |
| Change turnover |
4,287
|
8,348 | |
| Change turnover % |
-17%
|
16%
|
46% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.